Probiotic supplementation to mitigate berotralstat gastrointestinal side effects: a multicenter case series from the ITACA network

IntroductionBerotralstat, the first oral plasma kallikrein inhibitor approved for hereditary angioedema (HAE) prophylaxis, may be associated with gastrointestinal (GI) side effects, particularly during the first three months of therapy. Probiotics have been shown to reduce GI disturbances in several...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Antonio Gidaro, Maria Domenica Guarino, Francesco Arcoleo, Donatella Bignardi, Cristian D’Antonio, Luisa Brussino, Pietro Accardo, Stefania Nicola, Stefano Pucci, Miriam Cognigni, Valentina Popescu Janu, Chiara Cogliati, Emanuele Bizzi, Mauro Cancian
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2026-04-01
סדרה:	Frontiers in Immunology
נושאים:	berotralstat gastrointestinal side effects hereditary angioedema ITACA long term prophylaxis microbiome
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1790199/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!